Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder

Current Opinion in Pediatrics

Volumn 18, Issue 4, 2006, Pages 427-434

  Poulton, Alison ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE   (Australia)

Author keywords

Attention deficit hyperactivity disorder; Growth; Sexual maturation; Stimulant medication

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BODY HEIGHT; BODY WEIGHT; CATCH UP GROWTH; CHILD; CHILD GROWTH; CHRONIC DRUG ADMINISTRATION; GROWTH DISORDER; GROWTH RATE; HUMAN; PRIORITY JOURNAL; REVIEW; SEXUAL MATURATION; SHORT STATURE; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY HEIGHT; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; GROWTH DISORDERS; HUMANS; SEXUAL MATURATION;

EID: 33747504202     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000236394.94827.4c     Document Type: Review

References (41)

1. Safer DJ, Allen RP, Barr E. Depression of growth in hyperactive children on stimulant drugs. N Engl J Med 1972; 287:217-220.
2. Safer DJ, Allen RP. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children. Pediatrics 1973; 51:660-667.
3. Safer DJ, Allen RP, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr 1975; 86:113-116.
4. Vaughan VC. Growth and development. In: Nelson WE, Vaughan VC, McKay RJ, editors. Textbook of pediatrics. Philadelphia: Saunders; 1969. pp. 15-57.
5. Satterfield JH, Cantwell DP, Schell A, Blaschke T. Growth of hyperactive children treated with methylphenidate. Arch Gen Psychiatry 1979; 36:212-217.
6. Greenhill LL, Puig-Antich J, Chambers W, et al. Growth hormone, prolactin, and growth responses in hyperkinetic males treated with D-amphetamine. J Am Acad Child Psychiatry 1981; 20:84-103.
7. Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983; 40:317-321.
8. Klein RG, Landa B, Mattes JA, Klein DF. Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Arch Gen Psychiatry 1988; 45:1127-1130.
9. Spencer T, Biederman J, Wright V, Danon M. Growth deficits in children treated with desipramine: a controlled study. J Am Acad Child Adolesc Psychiatry 1992; 31:235-243.
10. Spencer TJ, Biederman J, Harding M, et al. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996; 35:1460-1469.
11. Poulton A, Cowell CT. Slowing of growth in height and weight on stimulants: a characteristic pattern. J Paediatr Child Health 2003; 39:180-185.
12. Lisska MC, Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 2003; 16:711-718.
13. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113:762-769.
14. Faraone SV, Monuteaux M, Spencer T. Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 2005; 15:191-202. Very useful and detailed longitudinal analysis of growth data in a large, multicenter study.
15. Millichap JG, Millichap M. Growth of hyperactive children. N Engl J Med 1975; 292:1300.
16. Quinn PO, Rapoport JL. One year follow up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 1975; 132:241-245.
17. Gross MD. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. Pediatrics 1976; 58:423-431.
18. McNutt BA, Boileau RA, Cohen MN. The effects of long-term stimulant medication on the growth and body composition of hyperactive children. Psychopharmacol Bull 1977; 13:36-38.
19. Millichap G. Growth of hyperactive children treated with methylphenidate. J Learn Disabil 1978; 11:40-43.
20. Kaffman M, Sher A, Bar-Sinai N. MBD children - variability in developmental patterns or growth inhibitory effect of stimulants? Israel Ann Psychiatry 1979; 17:58-66.
21. Kalachnik JE, Sprague RL, Sleator EK, et al. Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol 1982; 24:586-595.
22. Vincent J, Varley CK, Leger P. Effects of methylphenidate on early adolescent growth. Am J Psychiatry 1990; 147:501-502.
23. Gadow KD, Sverd J, Sprafkin J, et al. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry 1999; 56:330-336.
24. Sund AM, Zeiner P. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children? Nordic J Psychiatry 2002; 56:53-57.
25. Wilens T, Pelham W, Stein M, et al. ADHD treatment with once daily OROS Methylphenidate: interim 12 month results from a long term open label study. J Am Acad Child Adolesc Psychiatry 2003; 42:424-433.
26. Biederman J, Faraone SV, Monuteaux MC, et al. Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development and treatment. Pediatrics 2003; 111:1010-1016.
27. Weiss G, Kruger E, Danielson U, Elman M. Effect of long term treatment of hyperactive children with methylphenidate. CMAJ 1975; 112:159-165.
28. Hamill PV, Drizd TA, Johnson CL, et al. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32:607-629.
29. Roche AF, Wainer H, Thissen D. Predicting adult stature for individuals. Monogr Paediatr 1975; 3:1-114.
30. Oettinger L, Gauch RR, Majovski LV. Maturity and growth in children with MBD. In: Millichap JG, editor. Learning disabilities and related disorders. Chicago: Year Book Medical; 1977. pp. 141-149.
31. Kuczmarski RJ, Ogden CL, Guo L, et al. CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 2000; 11:1-201.
32. Greulich WM, Pyle SJ. Radiographic atlas of skeletal development in the hand and wrist. Stanford: Stanford University Press; 1964.
33. McGee R, Birkbeck J, Silva PA. Physical development of hyperactive boys. Dev Med Child Neurol 1985; 27:364-368.
34. Schlager G, Newman DE, Dunn HG, et al. Bone age in children with minimal brain dysfunction. Dev Med Child Neurol 1979; 21:41-51.
35. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:1073-1086.
36. Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, doubleblind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics 2002; 110:258-266.
37. Poulton A. Is the effect of stimulant medication on growth linked to its therapeutic effect? J Child Adolesc Psychopharmacol 2006 (in press)
38. Poulton A. Growth on stimulant medication; clarifying the confusion: a review. Arch Dis Child 2005; 90:801-806. Detailed analysis of 29 growth studies, reviewing each study's results in the context of the methodology.
39. Schertz M, Adesman AR, Alfieri NE, Bienkowski RS. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics 1996; 98:763-769.
40. Kramer JR, Loney J, Ponto LB, et al. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. J Am Acad Child Adolesc Psychiatry 2000; 39:517-524.
41. Hechtman L, Weiss G, Perlman T. Growth and cardiovascular measures in hyperactive individuals as young adults and in matched normal controls. CMAJ 1978; 118:1247-1250.